{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:54:32Z","timestamp":1761580472719},"reference-count":9,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1182\/blood-2006-07-033233","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T20:49:10Z","timestamp":1170967750000},"page":"387-387","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Low-dose versus high-dose therapy for Gaucher disease: goals and markers"],"prefix":"10.1182","volume":"109","author":[{"given":"Carla E. M.","family":"Hollak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike de","family":"Fost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M. F. G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"vom Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111613304789500_B1","doi-asserted-by":"crossref","unstructured":"Zimran A, Elstein D, Beutler E. Cellular origin and lineage specificity of the JAK2V617F allele in polycythemia vera Blood Prepublished on April 25, 2006 as DOI 10.1182\/blood-2006-03-010801. (Now available as Blood. 2006;108:802-803).","DOI":"10.1182\/blood-2006-03-010801"},{"key":"2019111613304789500_B2","doi-asserted-by":"crossref","unstructured":"de Fost M, Hollak CE, Groener JE, et al. Superior effects of high dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a two center retrospective analysis. Blood Prepublished on March 9, 2006, as DOI 10.1182\/blood-2005-12-5072. (Now available as Blood. 2006;108:830-835).","DOI":"10.1182\/blood-2005-12-5072"},{"key":"2019111613304789500_B3","doi-asserted-by":"crossref","unstructured":"Hollak CE, Aerts JM, Goudsmit R, et al. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet1995; 345:1474\u20131478.","DOI":"10.1016\/S0140-6736(95)91037-9"},{"key":"2019111613304789500_B4","doi-asserted-by":"crossref","unstructured":"Colburn WA and Lee JW. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling. Clin Pharmacokinet2003; 42:997\u20131022.","DOI":"10.2165\/00003088-200342120-00001"},{"key":"2019111613304789500_B5","doi-asserted-by":"crossref","unstructured":"Weinreb NJ, Aggio MC, Andersson HC, et al. Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol2004; 41:(suppl 5), 15\u201322.","DOI":"10.1053\/j.seminhematol.2004.07.010"},{"key":"2019111613304789500_B6","doi-asserted-by":"crossref","unstructured":"Beutler E. Enzyme replacement in Gaucher disease. PLoS Med2004; 1:118\u2013121.","DOI":"10.1371\/journal.pmed.0010021"},{"key":"2019111613304789500_B7","doi-asserted-by":"crossref","unstructured":"Boven LA, van Meurs M, Boot RG, et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol2004; 122:359\u2013369.","DOI":"10.1309\/BG5VA8JRDQH1M7HN"},{"key":"2019111613304789500_B8","doi-asserted-by":"crossref","unstructured":"vom Dahl S, Poll LW, Ha\u0308ussinger D. Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher. Brit J Haematol2001; 113:1084\u20131086.","DOI":"10.1046\/j.1365-2141.2001.02821-9.x"},{"key":"2019111613304789500_B9","doi-asserted-by":"crossref","unstructured":"Maas M, Hollak CE, Akkerman EM. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. Am J Roentgenol2002; 179:961\u2013965.","DOI":"10.2214\/ajr.179.4.1790961"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/1\/387\/1295557\/zh800107000387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/1\/387\/1295557\/zh800107000387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T18:30:58Z","timestamp":1573929058000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/1\/387\/117141\/Lowdose-versus-highdose-therapy-for-Gaucher"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-07-033233","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}